Development and validation of a new HPlc method for determination of lamotrigine and clinical application
##plugins.themes.academic_pro.article.main##
Abstract
SUMMARY
Background: Lamotrigine is an effective anticonvulsant drug used in the treatment of epilepsy. It has a narrow therapeutic range, a large inter and intra-individual pharmacokinetic variability and some concentration-dependent side effects.
Aim: The aim of this study was to develop and validate a new method for lamotrigine quantitation in plasma using HPLC with UV/visible detection.
Methods: A rapid HPLC-UV method was developed for the determination of lamotrigine in plasma. All solvents used were HPLC grade.
Results: After liquid-liquid extraction, chromatographic separation was achieved using an RP 18 (250 mm) column. The mobile phase was composed of acetonitrile and 0.1 M potassium dihyrogenophosphate (25/75) (v/v). Barbital sodium was used as internal standard. This technique was linear over the 2 μg/mL to 50 μg/mL range (r= 0.99). Detection and quantification limits were 0.07 μg/mL and 0.21 μg/mL, respectively. Within-day coefficient of variation (13.37 to 16 %) and day-to-day coefficients of variation (15.68 to 16.63 %) at three different concentrations. Under these conditions, each analysis required no longer than 10 min. We finally evaluated the plasma concentrations of lamotrigine in Tunisian patients treated with this drug.
Conclusion: The results found are similar to those previously described and the developed method is repeatable and reproducible. It can be used for clinical applications.
Background: Lamotrigine is an effective anticonvulsant drug used in the treatment of epilepsy. It has a narrow therapeutic range, a large inter and intra-individual pharmacokinetic variability and some concentration-dependent side effects.
Aim: The aim of this study was to develop and validate a new method for lamotrigine quantitation in plasma using HPLC with UV/visible detection.
Methods: A rapid HPLC-UV method was developed for the determination of lamotrigine in plasma. All solvents used were HPLC grade.
Results: After liquid-liquid extraction, chromatographic separation was achieved using an RP 18 (250 mm) column. The mobile phase was composed of acetonitrile and 0.1 M potassium dihyrogenophosphate (25/75) (v/v). Barbital sodium was used as internal standard. This technique was linear over the 2 μg/mL to 50 μg/mL range (r= 0.99). Detection and quantification limits were 0.07 μg/mL and 0.21 μg/mL, respectively. Within-day coefficient of variation (13.37 to 16 %) and day-to-day coefficients of variation (15.68 to 16.63 %) at three different concentrations. Under these conditions, each analysis required no longer than 10 min. We finally evaluated the plasma concentrations of lamotrigine in Tunisian patients treated with this drug.
Conclusion: The results found are similar to those previously described and the developed method is repeatable and reproducible. It can be used for clinical applications.
Keywords:
Lamotrigine-HPLC-Therapeutic drug monitoring##plugins.themes.academic_pro.article.details##
References
- [La Roche S.M, Helmers S.L. The new antiepileptic drugs: Clinical applications. JAMA 2004; 291: 615-20.
- Fraser A D, MacNeil W, Isner A F, Camfield PR. Lamotrigine analysis in serum by high performance liquid chromatography. Therapeutic drug monitoring 1995; 17:174-78.
- Rivas N, Zarzuelo A, Lópezc FG. Optimization of a high-efficiency liquid chromatography technique for measuring lamotrigine in human plasma. Farmacia Hospitalaria 2010; 34:85-9.
- Emami J, Ghassami N, Ahmadi F. Development and validation of a new HPLC method for determination of lamotrigine and related compounds in tablet formulations. Journal of Pharmaceutical and Biomedical Analysis 2006; 40: 999-1005.
- Cheng CL, Chou CH, Hu OY. Determination of lamotrigine in small volumes of plasma by high-performance liquid chromatography. Journal of Chromatography B 2005; 817:199-206
- Barbosa N R, Mdio AF. Validated high-performance liquid chromatographic method for the determination of lamotrigine in human plasma. Journal of Chromatography B BIOMEDICAL Sciences and applications 2000; 741: 289-93
- Greiner-Sosanko E, Lower DR, Virji MA, Krasowski MD. Simultaneous determination of lamotrigine, zonisamide, and carbamazepine in human plasma by high-performance liquid chromatography. Biomed Chromatography 2007; 21: 225-228.
- Torra M, Rodamilans M, Arroyo S, Corbella J. Optimized procedure for lamotrigine analysis in serum by high-performance liquid chromatography without interferences from other frequently coadministered anticonvulsants. Therapeutic Drug Monitoring 2000 ; 22:621-5.